dataType: geneExpression genomicVariants image chromatinActivity studyName: DHART SPORE Project 3: A High Content Clinical Trial of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML). dataStatus: Under Embargo initiative: Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence studyLeads: Kevin Shannon Mignon Loh studyStatus: Active diseaseFocus: Neurofibromatosis type 1 institutions: University of California San Francisco fundingAgency: NIH-NCI manifestation: JMML relatedStudies: syn8012530 syn5714288 syn7217935 syn27762317 studyFileviewId: syn17038351 syn18137524 syn18913120 syn18143754 syn11528501